Cargando…

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees

Detalles Bibliográficos
Autores principales:	Yadav, Pragya D., Sapkal, Gajanan N., Sahay, Rima R., Patil, Deepak Y., Deshpande, Gururaj R., Jain, Rajlaxmi, Nyayanit, Dimpal A., Shete, Anita M., Suryawanshi, Annasaheb, Nandapurkar, Ashok, Gurav, Yogesh K., Abraham, Priya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934181/ https://www.ncbi.nlm.nih.gov/pubmed/35318093 http://dx.doi.org/10.1016/j.jinf.2022.03.016

Ejemplares similares

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months
por: Sahay, Rima R., et al.
Publicado: (2022)

SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera
por: Sahay, Rima R., et al.
Publicado: (2022)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
por: Yadav, Pragya D., et al.
Publicado: (2022)

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern
por: Yadav, Pragya D., et al.
Publicado: (2022)

Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022)

Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern
por: Mohandas, Sreelekshmy, et al.
Publicado: (2022)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
por: Shete, Anita M., et al.
Publicado: (2022)

SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021)

Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model
por: Yadav, Pragya, et al.
Publicado: (2022)

Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease
por: Yadav, Pragya D., et al.
Publicado: (2019)

Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells
por: Nyayanit, Dimpal A., et al.
Publicado: (2020)

Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India
por: Sahay, Rima Rakeshkumar, et al.
Publicado: (2022)

Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
por: Deshpande, Gururaj Rao, et al.
Publicado: (2020)

Identification and phylogenetic analysis of herpes simplex virus-1 from clinical isolates in India
por: Nyayanit, Dimpal A., et al.
Publicado: (2019)

A case with SARS-CoV-2 reinfection from India
por: Munivenkatappa, Ashok, et al.
Publicado: (2022)

Molecular characterization of varicella zoster virus isolated from clinical samples in India
por: Nyayanit, Dimpal Amol, et al.
Publicado: (2021)

Broadly Reactive SARS-CoV-2-Specific T-Cell Response and Participation of Memory B and T Cells in Patients with Omicron COVID-19 Infection
por: Yadav, Pragya D., et al.
Publicado: (2023)

Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection
por: Mohandas, Sreelekshmy, et al.
Publicado: (2020)

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants
por: Patil, Dilip R., et al.
Publicado: (2023)

Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis
por: Nyayanit, Dimpal A., et al.
Publicado: (2020)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model
por: Mohandas, Sreelekshmy, et al.
Publicado: (2021)

SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia
por: Munivenkatappa, Ashok, et al.
Publicado: (2021)

Sequential determination of viral load, humoral responses and phylogenetic analysis in fatal and non-fatal cases of Crimean-Congo hemorrhagic fever patients from Gujarat, India, 2019
por: Sahay, Rima R., et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by gamma irradiation
por: Jain, Rajlaxmi, et al.
Publicado: (2021)

Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India
por: Shastri, Jayanthi, et al.
Publicado: (2022)

Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021
por: Yadav, Pragya D., et al.
Publicado: (2022)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India
por: Sudeep, A. B., et al.
Publicado: (2021)

Clinico-epidemiological investigation on Varicella Zoster Virus indicates multiple clade circulation in Maharashtra state, India
por: Sahay, Rima R., et al.
Publicado: (2018)

Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
por: Behera, Priyamadhaba, et al.
Publicado: (2022)

Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients
por: Kaduskar, Ojas, et al.
Publicado: (2022)

Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
por: Deshpande, Gururaj Rao, et al.
Publicado: (2021)

Characterization of a strain of quaranfil virus isolated from soft ticks in India. Is quaranfil virus an unrecognized cause of disease in human and animals?”
por: Mourya, Devendra T., et al.
Publicado: (2019)

Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India
por: Shete, Anita M., et al.
Publicado: (2021)

Covaxin-Induced Lymphocytic Myocarditis
por: Mittal, Nitish, et al.
Publicado: (2022)

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022)

Study of Kyasanur forest disease viremia, antibody kinetics, and virus infection in target organs of Macaca radiata
por: Patil, Dilip R., et al.
Publicado: (2020)

Molecular characterization & recombination analysis of complete enterovirus-88 isolated from acute flaccid paralysis cases in India
por: Munivenkatappa, Ashok, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5fhe9u0imkcl0ho6a9k7siksej